iX Biopharma Ltd.

iX Biopharma Ltd.verified

42C.SI

Price:

$0.116

Market Cap:

$100.11M

iX Biopharma Ltd., a specialty pharmaceutical and nutraceutical company, develops, manufactures, and commercializes therapies for the treatment of acute and breakthrough pain, and other health conditions in Singapore, the United States, China, and Australia. The company operates through Specialty Pharmaceutical and Nutraceutical segments. It offers Wafesil and Silcap for the treatment of male erectile dysfunction; and Xativa, a sublingual cannabidiol wafer, as well as Hypera, a sublingual tetrahydrocannabinol wafer for chronic pain, anxiety, and insomnia. The company is also developing Wafermine, a racemic ketamine sublingual wafer, which has completed phase-2 clinical trial for the treatmen...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2015-07-22

Stock Exchange

SES

Ticker

42C.SI

The Enterprise Value as of December 2025 (TTM) for iX Biopharma Ltd. (42C.SI) is 105.14M

According to iX Biopharma Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 105.14M. This represents a change of 316.05% compared to the average of 25.27M of the last 4 quarters.

iX Biopharma Ltd. (42C.SI) Historical Enterprise Value (quarterly & annually)

How has 42C.SI Enterprise Value performed in the past?

The mean historical Enterprise Value of iX Biopharma Ltd. over the last ten years is 93.06M. The current 105.14M Enterprise Value has changed 11.20% with respect to the historical average. Over the past ten years (40 quarters), 42C.SI's Enterprise Value was at its highest in in the June 2015 quarter at 277.71M. The Enterprise Value was at its lowest in in the June 2025 quarter at 19.14M.

Quarterly (TTM)
Annual

Average

93.06M

Median

102.52M

Minimum

19.02M

Maximum

164.09M

iX Biopharma Ltd. (42C.SI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of iX Biopharma Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 544.42%

Maximum Annual Enterprise Value = 164.09M

Minimum Annual Increase = -73.07%

Minimum Annual Enterprise Value = 19.02M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202519.02M-25.93%
202425.68M-61.91%
202367.42M-40.82%
2022113.92M-30.58%
2021164.09M3.77%
2020158.13M544.42%
201924.54M-73.07%
201891.12M-32.46%
2017134.90M2.38%
2016131.76M-50.43%

iX Biopharma Ltd. (42C.SI) Average Enterprise Value

How has 42C.SI Enterprise Value performed in the past?

The current Enterprise Value of iX Biopharma Ltd. (42C.SI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

37.38M

5-year avg

78.03M

10-year avg

93.06M

iX Biopharma Ltd. (42C.SI) Enterprise Value vs. Peers

How is 42C.SI’s Enterprise Value compared to its peers?

iX Biopharma Ltd.’s Enterprise Value is greater than UG Healthcare Corporation Limited (84.58M), greater than HC Surgical Specialists Limited (49.84M), greater than Cordlife Group Limited (23.90M), less than Singapore Institute of Advanced Medicine Holdings Ltd. (123.44M), greater than Vicplas International Ltd (85.97M), greater than Embracing Future Holdings Limited (55.95M), greater than Medinex Limited (30.70M), greater than Niks Professional Ltd (22.05M), greater than Medi Lifestyle Limited (5.13M), greater than Clearbridge Health Limited (4.77M),

Build a custom stock screener for iX Biopharma Ltd. (42C.SI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like iX Biopharma Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

iX Biopharma Ltd. (42C.SI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like iX Biopharma Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is iX Biopharma Ltd.'s Enterprise Value?

What is the highest Enterprise Value for iX Biopharma Ltd. (42C.SI)?

What is the 3-year average Enterprise Value for iX Biopharma Ltd. (42C.SI)?

What is the 5-year average Enterprise Value for iX Biopharma Ltd. (42C.SI)?

How does the current Enterprise Value for iX Biopharma Ltd. (42C.SI) compare to its historical average?